These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma. Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318 [TBL] [Abstract][Full Text] [Related]
4. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells. Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450 [TBL] [Abstract][Full Text] [Related]
5. Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Sarkar S; Swiercz R; Kantara C; Hajjar KA; Singh P Gastroenterology; 2011 Feb; 140(2):583-595.e4. PubMed ID: 20826156 [TBL] [Abstract][Full Text] [Related]
6. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2. Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281 [TBL] [Abstract][Full Text] [Related]
7. Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors. Andey T; Bora-Singhal N; Chellappan SP; Singh M Nanomedicine; 2019 Jun; 18():31-43. PubMed ID: 30831275 [TBL] [Abstract][Full Text] [Related]
8. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2. Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840 [TBL] [Abstract][Full Text] [Related]
9. Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells. Zhang HJ; Yao DF; Yao M; Huang H; Wang L; Yan MJ; Yan XD; Gu X; Wu W; Lu SL World J Gastroenterol; 2013 Jun; 19(24):3792-801. PubMed ID: 23840117 [TBL] [Abstract][Full Text] [Related]
10. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708 [TBL] [Abstract][Full Text] [Related]
11. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216 [TBL] [Abstract][Full Text] [Related]
12. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer. Mukerjee A; Ranjan AP; Vishwanatha JK J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533 [TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling. Yi Y; Zeng S; Wang Z; Wu M; Ma Y; Ye X; Zhang B; Liu H Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):793-803. PubMed ID: 29253515 [TBL] [Abstract][Full Text] [Related]
14. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells. Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519 [TBL] [Abstract][Full Text] [Related]
16. Annexin A2-S100A10 Represents the Regulatory Component of Maxi-Cl Channel Dependent on Protein Tyrosine Dephosphorylation and Intracellular Ca²⁺. Islam MR; Okada T; Merzlyak PG; Toychiev AH; Ando-Akatsuka Y; Sabirov RZ; Okada Y Cell Physiol Biochem; 2020 May; 54(4):538-555. PubMed ID: 32442363 [TBL] [Abstract][Full Text] [Related]
17. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma. Chen CY; Lin YS; Chen CL; Chao PZ; Chiou JF; Kuo CC; Lee FP; Lin YF; Sung YH; Lin YT; Li CF; Chen YJ; Chen CH Oncotarget; 2015 Sep; 6(29):26946-59. PubMed ID: 26196246 [TBL] [Abstract][Full Text] [Related]
18. Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. Braden AR; Kafka MT; Cunningham L; Jones H; Vishwanatha JK J Nanosci Nanotechnol; 2009 May; 9(5):2856-65. PubMed ID: 19452941 [TBL] [Abstract][Full Text] [Related]
19. Effect of shRNA mediated down-regulation of Annexin A2 on biological behavior of human lung adencarcinoma cells A549. Wang YX; Lv H; Li ZX; Li C; Wu XY Pathol Oncol Res; 2012 Apr; 18(2):183-90. PubMed ID: 21688086 [TBL] [Abstract][Full Text] [Related]